Allspring Global Investments Holdings LLC Grows Stock Holdings in ...
π Allspring Global Investments Holdings LLC raised its Cencora holdings by 7.8% in Q1, adding 29,983 shares to a total position of 413,051 shares.
π¦ Multiple institutional investors including Kemnay Advisory Services Inc., Oakworth Capital Inc., and Motiv8 Investments LLC established new stakes valued between $25,000 and $29,000 in Q4.
π Cencora reported Q1 EPS of $4.75, missing analyst consensus estimates of $4.82 by $0.07 per share.
π° The company generated quarterly revenue of $78.36 billion, a 3.9% increase compared to the same quarter in the prior year.
π Cencora achieved a return on equity of 135.20% and maintained a net margin of 0.78% during the reported quarter.
π The Board of Directors approved a $2.00 billion share repurchase program, allowing the purchase of up to 3.9% of outstanding shares.
π΅ Cencora paid a quarterly dividend of $0.60 per share on June 1st, offering an annualized yield of 0.8%.
π Director Lauren M. Tyler purchased 550 shares for $148,626.50, increasing her personal ownership by 14.44% to 4,359 shares.
π Robert W. Baird reduced its price target from $420.00 to $339.00 while maintaining an 'outperform' rating.
π Citigroup lowered its price target from $405.00 to $355.00 but retained a 'buy' rating for the stock.
π Wells Fargo & Company cut its price objective from $429.00 to $331.00 with an 'overweight' rating.
π Bank of America increased its target price from $280.00 to $285.00 and issued a 'neutral' rating.
π― The consensus analyst target price for Cencora is currently set at $367.75 with an average rating of 'Moderate Buy'.
π’ Hedge funds and other institutional investors collectively own 97.52% of the company's outstanding stock.
π Insider ownership stands at 0.38%, with Director Lauren M. Tyler holding a significant portion of that stake.
- Allspring Global Investments Holdings LLC increased its position by 7.8% in Q1, signaling continued institutional confidence in the company.
- Several other large investors, including Kemnay Advisory Services Inc., Oakworth Capital Inc., and Motiv8 Investments LLC, established new positions valued between $25,000 and $29,000 in Q4.
- Archer Investment Corp significantly increased its holdings by 134.3% in Q4, demonstrating strong bullish sentiment from a specific investor.
- Cencora approved a substantial $2.00 billion share repurchase program, indicating management's belief that the stock is undervalued and a commitment to returning capital to shareholders.
- The company paid a quarterly dividend of $0.60 per share on June 1st, providing income to shareholders with an annualized yield of 0.8%.
- Director Lauren M. Tyler purchased 550 shares for $148,626.50, increasing her personal ownership by 14.44%, which often signals insider confidence in the company's future prospects.
- Cencora achieved a robust return on equity of 135.20% and maintained a positive net margin of 0.78% despite missing earnings estimates.
- Revenue grew by 3.9% year-over-year to $78.36 billion, demonstrating consistent top-line growth in the pharmaceutical distribution sector.
- Cencora missed quarterly earnings estimates, reporting EPS of $4.75 against analyst consensus of $4.82, a miss of $0.07 per share.
- Quarterly revenue of $78.36 billion fell short of analyst expectations of $81.09 billion, indicating potential headwinds in the distribution market.
- Multiple major analysts reduced their price targets, with Robert W. Baird cutting from $420.00 to $339.00, Citigroup from $405.00 to $355.00, and Wells Fargo from $429.00 to $331.00.
- The consensus analyst target price of $367.75 is significantly below the recent high price targets mentioned by analysts like Robert W. Baird ($420.00) and Citigroup ($405.00), suggesting a downward revision in valuation expectations.